Skip to content
Government NSW, Medical Health Aged Care

MEDIA ALERT: Heart Week 2024 event today at NSW Parliament

Heart Foundation < 1 mins read

This year’s event promises to be an engaging and insightful experience at NSW Parliament House 

 

When:  Today, Wednesday 8th May

Time: 12:30pm to 2:30pm

Where: Ground Level, Fountain Courtyard, Parliament House NSW

Who:  David Lloyd, Heart Foundation CEO 

      Natalie Raffoul, Senior Healthcare Programs Manager, Heart Foundation

  

During this event, you can explore our Activation Space, designed to engage, inform, and inspire. Here’s a glimpse into the activities planned: 

 

  • Meet Happy Heart: Our beloved heart health mascot will greet attendees and be available for a photo. 
  • Heart Health Checks: A cornerstone of our advocacy, these checks are crucial for early detection and management of heart health risks. We encourage you to experience one firsthand. 
  • Jump Rope for Heart Demonstration: Witness the energy of our flagship program, which combines fun and fitness and showcases the importance of physical activity for heart health.

 

Learn more about Heart Foundation initiatives like our national walking program, the cardiac rehab program MyHeart MyLife, healthy eating resources and the NSW Cardio Vascular Research Network.


Contact details:

Shaun Inguanzo

Media Manager

0404 769 054

More from this category

  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

  • Medical Health Aged Care, Science
  • 13/09/2024
  • 11:08
La Trobe University

Centre to play key role in global AI medical research

Artificial intelligence promises to unlock new cures for cancer and other diseases by revolutionising the speed, cost and availability of personally designed drugs and enabling these to be tested on “digital twins" before being given to patients. AI will enable broad-spectrum like chemotherapy to be replaced by these more personalised, better targeted treatments. Scientists at La Trobe University's new Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI), launched today, will also apply AI techniques to mRNA therapy development to enable faster design of more precise and effective treatments. Vice-Chancellor Professor Theo Farrell said ACAMI would sit within La Trobe’s…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.